MERLIN_001
A prospective registry study evaluating a primary melanoma gene signature for sentinel node prediction and prognostic stratification.
The clinical question
Gene expression profiling has been proposed as a way to add biologic information to conventional clinicopathologic risk assessment in melanoma.
This Research Forum session focused on the MERLIN_001 study and its evaluation of a primary melanoma gene signature designed to predict sentinel node status and refine prognostic assessment in patients with sentinel node-negative disease.
Central Question
Can molecular information from the primary melanoma meaningfully improve prediction of sentinel node status and subsequent prognosis?
Questions explored
Sentinel node prediction
Can a melanoma gene signature identify patients with a lower or higher probability of sentinel lymph node positivity?
Prognostic value
Among patients with a negative sentinel node, can molecular profiling further distinguish clinically meaningful differences in risk?
The MERLIN_001 study
MERLIN_001 was presented as a prospective registry study evaluating a primary melanoma gene signature for two related purposes: predicting sentinel node status and determining whether the signature provides additional prognostic information for patients with sentinel node-negative melanoma.
The broader discussion centered on how such molecular information should be interpreted alongside established clinical and pathologic features rather than in isolation.
Why It Matters
The clinical value of gene expression profiling depends not simply on whether it is prognostic, but on whether it meaningfully improves decisions beyond information already available from conventional staging and clinicopathologic risk factors.
Research Forum focus
The session provided an opportunity to examine the MERLIN results in the broader context of melanoma staging, sentinel lymph node biopsy, prognostic biomarkers, and the appropriate role of molecular testing in clinical decision-making.
Society of Cutaneous Oncology Research Forum. Research discussions presented through the Forum may include evolving evidence and should be interpreted in that context.